Potential role of natural molecules in health and disease importance of boswellic acid

Journal of Medicinal Plants Research

Volumn 4, Issue 25, 2010, Pages 2778-2785

  Qurishi, Yasrib ^a   Hamid, Abid ^a   Zargar, M A ^b   Singh, Shashank Kumar ^a   Saxena, Ajit Kumar ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b UNIVERSITY OF KASHMIR   (India)

Author keywords

Boswellic acid; Drugs; Natural products; Signaling

Indexed keywords

11 KETO BETA BOSWELLIC ACID; 3 ACETYL 11 KETO BETA BOSWELLIC ACID; ALCOHOL; BOSWELLIA SERRATA EXTRACT; BOSWELLIC ACID; MESALAZINE; NATURAL PRODUCT; PLANT MEDICINAL PRODUCT; SALAZOSULFAPYRIDINE; TERPENOID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ASTHMA; BOSWELLIA; BOSWELLIA SERRATA; BRAIN EDEMA; BRAIN METASTASIS; BREAST CANCER; COLON CANCER; COLORECTAL CANCER; DRUG DETERMINATION; DRUG EFFICACY; DRUG INFORMATION; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; ENCEPHALITIS; GEOGRAPHIC DISTRIBUTION; GLIOBLASTOMA; HEPATITIS; HERBAL MEDICINE; HUMAN; HYPOLIPEMIA; ILEITIS; NEOPLASM; NONHUMAN; OSTEOARTHRITIS; REVIEW; SARCOMA 180; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; VARIETAS;

BOSWELLIA; BOSWELLIA SERRATA;

EID: 79251590751     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Azaizeh H, Saad B, Cooper E, Said O (2008). Traditional Arabic and Islamic Medicine, a Re-emerging Health Aid. Evid Based Complement Alternat Med.
2. Badel T, Keros J, Krapac L, Pavicin IS (2010). Relationship between osteonecrosis of the jaw and bisphosphonate treatment. Arh Hig Rada Toksikol., 61(3): 371-380.
3. Belakavadi M, Bharathi PS (2004). Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase.
4. Ben NK, Moulin AM (2010). The North African plague and Charles Nicolle's theory of infectious diseases. Gesnerus, 67(1): 30-56.
5. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME (2008). The immunobiology of mushrooms. Exp. Biol. Med., 233(3): 259-276.
6. Canuso AA, McLay RN, Bennett JH, Pyne JM, Munoz KB, Stenback KA (2008). Schizophreniform disorder after heat injury in a military recruit. Psychosomatics, 49(4): 345-346.
7. Castelli M, Malagoli M, Lupo L, Roffia S, Paolucc F, Cermelli C, Zanca A, Baggio G (2000). Cytotoxicity and probable mechanism of action of sulphimidazole. J. Antimicrob. Chemother., pp. 541-550.
8. Chen G, Zhu L, Liu Y, Zhou Q, Chen H, Yang (2009). J. Isoliquiritigenin, a flavonoid from licorice, plays a dual role in regulating gastrointestinal motility in vitro and in vivo. Phytother. Res. Apr., 23(4): 498-506.
9. Chiang HM, Xia Q, Chen T, Chen BH, Yin JJ, Wen KC, Lin G, Yu H (2009). Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev., 27(2): 91-119.
10. Connor JR, LePage C, Swift BA, Yamashita D, Bendele AM, Maul D, Kumar S (2009). Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis. Osteoarthritis Cartilage, 9: 1236-1243.
11. Dolle L, Depypere HT, Bracke ME (2006). Anti-invasive/anti-metastasis strategies: new roads, new tools and new hopes. Curr. Cancer Drug Targets., pp. 729-751.
12. Doucas H, Garcea G, Neal CP, Manson MM, Berry DP (2006). Chemoprevention of pancreatic cancer: A review of the molecular pathways involved, and evidence for the potential for chemoprevention. Pancreatology, 6(5): 429-439.
13. Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, Markova L, Urban M, Sarek J (2006). Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep., 23(3): 394-411.
14. Farid AB, Botros RM, Galal TM, Mohamed MA (2003). Immunomodulatory Triterpenoids from the Oleogum Resin of Boswellia carterii Birdwood, pp. 505-516.
15. Frank MB, Yang Q, Osban J, Azzarello JT, Saban MR, Saban R, Ashley RA, Welter JC, Fung KM, Lin HK (2009). Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity. BMC Complement Altern. Med., 9: 6.
16. Singh GB, Atal CK (1993). Dehydrozingerone and isoeugenol as inhibitors of lipid peroxidation and as free radical scavengers J. Ethnopharmacol., pp. 105-112.
17. Gautam R, Jachak SM, Saklani A (2010). Anti-inflammatory effect of Ajuga bracteosa Wall Ex Benth. mediated through cyclooxygenase (COX) inhibition. J. Ethnopharmacol. pp. 928-930.
18. Gieseler F, Boege F, Clark M, Meyer P (1993). Correlation between the DNA-binding affinity of topoisomerase inhibiting drugs and their capacity to induce hematopoetic cell differentiation. Toxicol. Lett., 67(1-3): 331-340.
19. Gokaraju (2004). Analogs of 3-O-acetyl-11-keto--boswellic acid, United States Patent 7625947.
20. Havel J, Patocka J, Bocaz G (2002). Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis. J. Capill. Electrophor. Microchip. Technol., pp: 107-112.
21. Jose MM, Cristina PG, Miguel B. (2000). Chemical and biological activity of free radical 'scavengers' in allergic disease, pp. 1-1.
22. Juan MD (2008). Risks and Benefits of Generic Antiepileptic Drugs. The neurologist, pp. 428-431.
23. Jurjus AR, Khoury NN, Reimund JM (2004). Animal models of inflammatory bowel disease.
24. Kapil M, Jansina YF (2009).Targeting Transglutaminase-2 to overcomChemoresistance in Cancer Cells, pp. 95-114.
25. Kartal M (2007). Intellectual Property Protection in the Natural Product Drug Discovery, Traditional Herbal Medicine and Herbal Medicinal Products. Phytother. Res., pp. 113-119.
26. Kuo RY, Qian K, Morris-Natschke SL, Lee KH (2009). Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents. Nat. Prod. Rep., 26(10): 1321-1344.
27. Lambert T (2006), China's Christian Millions, Monarch Books, Oxford, pp. 59-60.
28. Landvik NE, Arlt VM, Nagy E, Solhaug A, Tekpli X, Schmeiser HH, Refsnes M, Phillips DH, Gossmann D, Holme JA (2000). 3- Nitrobenzanthrone and 3-aminobenzanthrone induce DNA damage and cell signalling in Hepa1c1c7 cells.
29. Langenheim JF, Chen WY (2009). Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor. J. Recept. Signal Transduct. Res., 29(2): 107-112.
30. Liu JJ, Nilsson A, Oredsson S, Badmaev V, Duan RD (2002). Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int. J. Mol. Med., 10(4): 501-505.
31. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, Odensten M, Ryd L, Sernbo I, Suomalainen O, Tegnander A (1996). Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: A randomised, double blind, placebo controlled multicentre trial. Ann. Rheum., Dis., 55: 424-431.
32. Madhuri S, Pandey G (2009). Some anticancer medicinal plants of foreign origin. Current Sci., 96: 6.
33. Mahmood ZA, Sualeh M, Zafar Mahmood SB, Karim MA (2010). Herbal treatment for cardiovascular disease the evidence based therapy. Pak. J. Pharm. Sci., 23(4): 119-124.
34. Makare N, Bodhankar S, Rangari V (2001). Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice. J. Ethnopharmacol., pp. 133-137.
35. Meadows M (2007). Keeping up with vaccines. FDA Consum., 41(1): 23-31.
36. Mercola J (2003). Managing hypertriglyceridemia. CMAJ., 168(7): 831-832.
37. Min L, Xia L, Hua H, Yongkui J (2004). Inhibition of IB Kinase Activity by Acetyl-boswellic Acids Promotes Apoptosis in Androgen-independent PC-3 Prostate Cancer Cells in vitro and in vivo. Cancer Res., 68: 4.
38. Neelam M, Subhash B, Vinod R (2000). Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice; J. Ethnopharmacol., pp. 133-137.
39. Neuzil J, Tomasetti M, Zhao Y, Dong LF, Birringer M, Wang XF, Low P, Wu K, Salvatore BA, Ralph SJ (2007). Vitamin E analogs, a novel group of mitocans, as anticancer agents: the importance of being redox-silent. Mol. Pharmacol., pp. 1185-1199.
40. Paharia A, Yadav AK, Rai G, Jain SK, Pancholi SS, Agrawal GP (2007). Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS Pharm. Sci. Tech., 8(1): 12.
41. Patwardhan B, Vaidya AD (2010). Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches. Indian J. Exp. Biol., 48(3): 220-227.
42. Pawel RK, Anna JM, Nesrin K, Shivanand DJ, Anikó MS, David GB, Barbara NT, Fayez KG (2004). Effects of Boswellia serrata in mouse models of chemically induced colitis.
43. Petra L (2005). Cytotoxic Compounds of Plant Origin-Biological and Chemical Diversity.
44. Poeckel D, Werz O (2006). Boswellic acids: biological actions and molecular targets. Curr. Med. Chem., 13(28): 3359-3369.
45. Pors K, Frederick WG, Christopher P, Leamon, Alan CR, Scott AS, Falconer RA (2009). The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow. Drug Discovery Today, pp. 1045-1050.
46. Rao NN, Dubey AK, Mohanty S, Khare P, Jain R, Kaul SN (2003). Photocatalytic degradation of 2-chlorophenol: A study of kinetics, intermediates and biodegradability. J. Hazard Mater., 101(3): 301-314.
47. Ray HN, Harbans S (1948). Effect of pantothenic acid on the infection of Trypanosoma evansi in rats. Nature, 162(4126): 849.
48. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon H P(1992). Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase, 3: 1143-1146.
49. Samy RP, Pushparaj PN, Gopalakrishnakone P (2008). A compilation of bioactive compounds from Ayurveda. Bioinformation, 3(3): 100-110.
50. Scheck AC, Perry K, Hank NC, Clark WD (2006). Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells. BMC Complement. Altern. Med., 6: 27.
51. Singh S, Khajuria A, Taneja SC, Johri RK, Singh J, Qazi GN (2008). Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine, 15(6-7): 400-407.
52. Syrovets T, Büchele B, Gedig E, Slupsky JR, Simmet T (2000). Acetyl-Boswellic Acids Are Novel Catalytic Inhibitors of Human Topoisomerases I and Ii[1] Molecular Pharmacology, 58: 71-81.
53. Tan Z (2009). Erratum: Neural protection by naturopathic compoundsan example of tetramethylpyrazine from retina to brain. J. Ocul. Biol. Dis. Inf., 2(3): 137-144.
54. Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME (2005). The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression, J. Biol. Chem., pp: 3483-3492.
55. Vlietinck A, Pieters L, Apers S (2009). Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union. Planta Med., 75(7): 683-688.
56. Weber CC, Reising K, Müller WE, Schubert-Zsilavecz M, Abdel-Tawab M (2006). Modulation of Pgp function by boswellic acids. Planta Med., 6: 507-513.
57. Zhao W, Entschladen F, Liu BSH, Fang NQ, Kurt SZ, Han R (2003). Cancer Detection and Prevention. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells, pp. 67-75.
58. Zhong Z, Zhi YZ, Wang J, Guo LL, Wang YY (2006). Study on combination components and effectiveness of Chinese traditional herbal formulas, 31(1): 5-9.